[ACRX] YoY Quarter Result on 30-Jun-2019 [#Q2]

Stock
[ACRX] AcelRx Pharmaceuticals, Inc.
Announcement Date
05-Aug-2019
Financial Year
2019
Quarter
30-Jun-2019 [#Q2]
Profit Trend
QoQ- 9.23%
YoY- -17.75%
Quarter Report
ACRX's Result
ACRX's Financial Summary
View:
Show?
Quarter Result
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
Revenue 570 443 2,924 941 818 2,659 4,531 -29.20%
PBT 70,666 -9,846 -6,602 -12,409 -10,539 -13,057 -11,092 -
Tax 3 5 4 3 2 2 -2,083 -
NP 70,663 -9,851 -6,606 -12,412 -10,541 -13,059 -11,092 -
Tax Rate -0.00% - - - - - - -
Total Cost -70,093 10,294 9,530 13,353 11,359 15,718 15,623 -
Ratio Analysis
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
NP Margin 12,397.02 -2,223.70 -225.92 -1,319.02 -1,288.63 -491.12 -244.80 -
Per Share
30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 CAGR
EPS 9.60 -1.65 -1.64 -3.15 -4.07 -5.76 -4.90 -
EPS Diluted 9.60 -1.65 -1.64 -3.15 -4.07 -5.76 -4.90 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.